This federal contract award (SPE2DB20D3505|SPE2DB21FU2W5) was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $6,482.88, is a delivery order with a firm fixed price.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company is Cencora, Inc., which also does business as AmerisourceBergen, further demonstrating the company's extensive capabilities in providing critical pharmaceutical and medical supplies to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.